Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $5.31 Analyst target: $24.33 Upside: 358.19%
Eikon Therapeutics, Inc., is a clinical biopharmaceutical company in the United States. The company is headquartered in Millbrae, California.
See the full interactive analysis & chart →Informational only — not investment advice.